The objectives of this clinical research project are to demonstrate the safety and feasibility of CAVU Medical, Inc.'s Attune Device.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
40
The CAVU Attune device is used with LAGB.
Institute of Weight Control
Baulkham Hills, New South Wales, Australia
St. George Private Hospital
Kogarah, New South Wales, Australia
The rate of successful placement and filling of the CAVU Medical Attune device without serious device-related adverse events.
Time frame: 30 Days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.